TL;DR: Biostimulators are injectable treatments that stimulate the body’s own collagen production, rather than adding volume directly. Unlike traditional fillers, they improve skin quality from within over a period of weeks to months. London’s most respected clinics are recommending them as a first-line approach to skin laxity and quality decline, particularly for patients seeking natural, gradual results with no downtime.
There is a quiet shift happening in the consulting rooms of London’s most respected aesthetic clinics. The era of volume-led treatment is giving way to something more considered: approaches that work with the body’s own biology rather than compensating for what has been lost. At the centre of this shift are biostimulators, a category of injectable treatments that trigger the skin’s natural collagen synthesis rather than replacing lost volume with a foreign substance. For Dr. Priyanka Chadha, Consultant Plastic Surgeon at Amer Clinic and global Key Opinion Leader for Galderma, they represent a fundamental evolution in how the industry thinks about ageing.
The Difference Between Biostimulators and Traditional Fillers
To understand why biostimulators have become so central to contemporary aesthetic practice, it helps to understand what they are not. Hyaluronic acid fillers, the staple of the previous decade, work by occupying space within the tissue, restoring volume and temporarily softening lines. They produce immediate results but require regular maintenance, and when overused or misapplied, can contribute to a heavy, distorted appearance that has become broadly recognised as overdone. Biostimulators operate on an entirely different principle. Rather than filling a space, they introduce a substance that the body reads as a signal to begin producing new collagen. The result is a gradual, structural improvement in skin quality that, to an external observer, looks entirely natural.
How Biostimulators Work
The mechanism differs between products, but the outcome is consistent: new collagen, laid down by the patient’s own fibroblasts, over a period of weeks to months. Sculptra, manufactured from poly-L-lactic acid by Galderma, was the first biostimulator to achieve widespread clinical adoption. Injected into the deep dermis and subcutaneous tissue, it prompts fibroblast activity and leads to a diffuse improvement in skin thickness, elasticity, and overall quality. Results are typically visible at six to eight weeks and continue to improve for up to six months. Profhilo, made from a high concentration of both high- and low-molecular-weight hyaluronic acid, spreads through the tissue and stimulates collagen and elastin production across a broad area. Unlike conventional fillers, it does not remain in one place, which makes it particularly suited to areas where diffuse rejuvenation rather than targeted volume is the goal.
Why London’s Most Respected Clinics Are Recommending Biostimulators
The shift has been building for several years, but it has accelerated as the aesthetic industry has engaged seriously with the consequences of volume-based overtreatment. Dr. Chadha, who sits on Galderma’s global advisory board and trains practitioners internationally in advanced injection technique, has been vocal about the need to recalibrate. “What I see consistently in patients who come to me after treatment elsewhere is that they have been given volume when what they needed was quality,” she says. “Biostimulators restore what the skin has lost at the structural level. The face looks better because it is better, not because something has been added on top of it.” This perspective is now widely shared among London’s Consultant Plastic Surgeons and specialist aesthetic practitioners working at the highest level of the discipline.
The Ideal Patient for Biostimulator Treatment
Biostimulators are not universally appropriate, and the discernment of the prescribing clinician remains the most important variable in achieving a good outcome. As a broad principle, patients who benefit most are those experiencing skin laxity and quality decline rather than significant volume loss. They are often in their late thirties to mid-fifties, concerned by a general loss of firmness and brightness, and keen to avoid anything that will make them look different rather than better. The neck, décolletage, and hands are areas where skin biostimulators in London specialists such as Dr. Chadha, treat routinely, as these areas do not tolerate volume addition well but respond beautifully to collagen stimulation.
Combining Biostimulators with Other Treatments
In practice, biostimulators are rarely used in isolation at the highest level of aesthetic medicine. Dr. Chadha’s approach begins with a full structural assessment of the face, neck, and relevant areas, mapping where volume loss, laxity, and quality decline are each contributing to the overall picture. From that foundation, she designs a protocol that may combine biostimulators with radiofrequency microneedling, HIFU, or, where appropriate, surgical intervention. “Biostimulators do one thing exceptionally well,” she explains, “and that is to rebuild the biological scaffolding of the skin. When you pair that with something that addresses surface texture or repositions deep tissue, the results become genuinely transformative. But only when the sequencing and rationale are correct.”
What to Expect from a Biostimulator Treatment
A biostimulator consultation at a clinic of Amer Clinic’s calibre begins long before a syringe is picked up. Dr. Chadha conducts a detailed medical history, reviews prior treatments, assesses facial anatomy in repose and in movement, and discusses the patient’s aesthetic goals in depth. Treatment itself is typically delivered across two to three sessions, spaced six to eight weeks apart, with results continuing to develop over the following months. There is minimal downtime: some patients experience mild swelling or bruising at injection sites, which resolves within a few days. The full collagen response unfolds over three to six months, and results can last eighteen months to two years before a maintenance session is warranted.
Why Clinical Expertise Is Non-Negotiable
Biostimulators have a narrower margin for error than they might appear. Because results develop gradually and do not produce the immediate visual feedback that a filler does, an inexperienced injector can under- or over-treat a patient without either party being aware until weeks later. Nodule formation, uneven distribution, and missed opportunities for anatomical correction are all risks that increase significantly in less experienced hands. The safest and most effective outcomes come from collagen stimulator treatment delivered by a clinician with deep anatomical knowledge, extensive product-specific training, and the surgical perspective to understand how injectable treatment interacts with the underlying structure of the face. Dr. Chadha’s dual background in surgical and non-surgical practice is precisely what makes her assessments so thorough.
Frequently Asked Questions
How long do biostimulator results last?
Results vary by product and patient, but most biostimulators produce improvements that last between eighteen months and two years. Sculptra results can persist beyond two years in some patients. Annual or biannual maintenance is typically recommended to sustain the improvement.
Are biostimulators safe?
When administered by a qualified and experienced clinician, biostimulators have an excellent safety profile. The substances used are well-studied and, in the case of poly-L-lactic acid and hyaluronic acid, are biocompatible and biodegradable. As with any injectable treatment, risks increase significantly when treatment is performed outside a medical setting or by an inadequately trained practitioner.
Can biostimulators replace dermal fillers entirely?
For some patients, yes. For others, a combination approach using both biostimulators and small amounts of targeted filler remains the most appropriate strategy. The right answer depends entirely on the individual’s anatomy, degree of volume loss, and aesthetic goals, which is precisely why a consultation with a Consultant Plastic Surgeon is so valuable.
How are biostimulators different from skin boosters?
Skin boosters such as Restylane Skinboosters primarily hydrate the skin by introducing small amounts of hyaluronic acid. Biostimulators trigger new collagen and elastin production. The effects of biostimulators are therefore more structural and longer-lasting, though both have a role in a comprehensive skin health strategy.
About the Expert: Dr. Priyanka Chadha
Dr. Priyanka Chadha is a Consultant Plastic Surgeon at Amer Clinic, Kensington, and a global Key Opinion Leader for Galderma. She holds FRCS (Plast), trained at Imperial College London, and consults at Guy’s and St Thomas’ NHS Trust. Her approach to injectable treatment is rooted in surgical precision: every treatment decision is made with a complete understanding of facial anatomy and a clear rationale for each element of the protocol. Consultations at Amer Clinic are designed as a dialogue between clinician and patient, with long-term outcome planning at their centre.
Dr. Priyanka Chadha
MBBS (London), BSc (Hons), DPMSA (London), MRCS (England), MSc (London), FRCS (Plast)
GMC No. 7293830
Consultant Plastic Surgeon, Amer Clinic, Kensington, London
